Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
OptiBiotix Health said subsidiary ProBiotix Health had signed a non-exclusive license agreement with Tenshindo for the use of Lactobacillus plantarum in cardiovascular food supplements in Japan.
Tenshindo was a manufacturer of functional food and cosmetics products founded in Japan in 1986.
Lactobacillus plantarum would be the active ingredient in a novel cardiovascular health product that Tenshindo would add to its current portfolio of over 50 products.
Tenshindo and ProBiotix would work together to obtain an authorised cardiovascular health claim from Japanese authorities, based on the existing clinical and market evidence on the strain.